Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
The Journal of Toxicological Sciences
|
February 1, 1991
Behavioral teratogenicity of methamphetamine
D H Cho, H M Lyu, H B Lee, et al.
Data in Brief
|
May 13, 2020
Laboratory data on long-term sealing behaviors of two water-swelling materials for shield tunnel gasket
J S Tan, S L Shen, A Zhou, et al.
Zhonghua Yi Xue Za Zhi
|
March 14, 2022
[Effect of progesterone receptor status on efficacy of aromatase inhibitors and survival time in patients with advanced breast cancer]
M W Zhang, H M Lyu, L M Niu, et al.
Zhonghua Yi Xue Za Zhi
|
October 25, 2021
[Resting-state functional magnetic resonance imaging analysis of modified electroconvulsive therapy in the treatment of major depressive disorder]
Q Q Hou, Y Wu, H M Lyu, et al.
Zhonghua Yi Xue Za Zhi
|
November 25, 2021
[Clinical observation of palbociclib combined with endocrine therapy in hormone receptor positive and HER2 negative advanced breast cancer]
H M Lyu, L M Niu, M W Zhang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
The Journal of Toxicological Sciences
|
February 1, 1991
Behavioral teratogenicity of methamphetamine
D H Cho, H M Lyu, H B Lee, et al.
Data in Brief
|
May 13, 2020
Laboratory data on long-term sealing behaviors of two water-swelling materials for shield tunnel gasket
J S Tan, S L Shen, A Zhou, et al.
Zhonghua Yi Xue Za Zhi
|
March 14, 2022
[Effect of progesterone receptor status on efficacy of aromatase inhibitors and survival time in patients with advanced breast cancer]
M W Zhang, H M Lyu, L M Niu, et al.
Zhonghua Yi Xue Za Zhi
|
October 25, 2021
[Resting-state functional magnetic resonance imaging analysis of modified electroconvulsive therapy in the treatment of major depressive disorder]
Q Q Hou, Y Wu, H M Lyu, et al.
Zhonghua Yi Xue Za Zhi
|
November 25, 2021
[Clinical observation of palbociclib combined with endocrine therapy in hormone receptor positive and HER2 negative advanced breast cancer]
H M Lyu, L M Niu, M W Zhang, et al.
Page
of 1